Lysosomal Acid Lipase Deficiency Treatment Market [+10.8% CAGR] Size to Expand Significantly by the End of 2031
Pune, Maharashtra, India, September 23 2022 (Wiredrelease) Prudour Pvt. Ltd --:The market size for (LAL) lysosomal acid lipse deficiency treatments was USD 380 millions in 2017. It is projected to experience a 10.8% CAGR over the forecast period. Market drivers include the increased use of enzyme replacement therapy and continued support care therapies. There are also high unmet need. Lysosomal Acid Lipase Deficiency (LALD) is an autosomal-recessive genetic disorder that affects cholesterol metabolism. The mutation in the lysosomal Acid Lipase gene (LIPA), which causes the accumulation of either triglyceride or cholesteryl esters within different tissues of the body, is the main…
- Date: September 23, 2022
- Author: Quintero
- Category: PharmiWeb